Callan JMB receives Nasdaq minimum bid price deficiency notice
Callan JMB Inc. received notice on June 29, 2026 from Nasdaq that its common stock failed to maintain the required minimum bid price of $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has until December 28, 2026 to regain compliance by achieving a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. If unsuccessful, it may qualify for an additional 180-day compliance period, and if still non-compliant thereafter, Nasdaq will issue a delisting notice, at which point the company may appeal to a Nasdaq Hearings Panel.
Key facts
- Notice received June 29, 2026 from Nasdaq Listing Qualifications Department
- Deficiency: closing bid price below $1.00 per share for last 30 consecutive business days
- Initial compliance period: 180 calendar days until December 28, 2026
- Compliance requirement: closing bid price of at least $1.00 per share for minimum of ten consecutive business days
- Secondary compliance period: additional 180 calendar days available if certain conditions met
- Company considering reverse stock split as option to regain compliance
Why it matters
The company has a 180-day cure period before delisting risk crystallizes; failure to meet the minimum bid price during that window could trigger a second compliance period or, ultimately, a delisting determination subject to appeal.
Share
Derived from 8-K filed 2026-07-02. Not investment advice. View the source filing on SEC.gov →